Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Insomnia in Migraineurs With Eszopiclone (Lunesta™) and Its Effect on Sleep Time, Headache Frequency, and Daytime Functioning: a Randomized, Double-blind, Placebo-controlled, Parallel-group Pilot Study

NCT00812214 is registered in ClinicalTrials.gov with MedVadis Research Corporation as lead sponsor.

NCT NCT00812214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00812214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Insomnia in Migraineurs With Eszopiclone (Lunesta™) and Its Effect on Sleep Time, Headache Frequency, and Daytime Functioning: a Randomized, Double-blind, Placebo-controlled, Parallel-group Pilot Study
Lead sponsor
MedVadis Research Corporation
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2007
Completion date
September 30, 2008
Enrollment
113 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, migraine